Category: LDC5

Blog / LDC5 / UN Meetings / UN Monitor

LDCs present VNRs at the HLPF (13–15 July 2021)

By Barbara Adams and Tejaswini Vavilala
The second PrepCom session will take place on 26-30 July 2021 and will launch negotiations on the Programme of Action for LDCs for the next decade, a decade that coincides with the last decade of the 2030 Agenda for Sustainable Development.
This is the last HLPF before the Doha conference / LDC5. During the HLPF Ministerial segment of the HLPF, eight LDCs will present their Voluntary National Reviews (VNRs), making a total of 53 LDC VNR presentations over the last six years, many by countries for the second, and some for a third, time. Read more

COVID-19 / LDC5 / UN Meetings / UN Monitor

CSO Perspectives on the LDC5 Programme of Action

By Elena Marmo and Alexa Sabatini
The Fifth UN Conference on the LDC5 will be held In Doha in January 2022. Preparations are already underway to negotiate the Outcome Document to be adopted in Doha, which will serve as a new 10-year Programme of Action for the LDCs.
On 20 May 2021, Co-Chairs of the LDC5 Preparatory Committee bureau–Rabab Fatima, Permanent Representative of Bangladesh and Bob Rae, Permanent Representative of Canada–facilitated a virtual consultation with CSOs, designed to address policy prescriptions that LDC5 must deliver to meet the needs of people and planet. Read more

COVID-19 / LDC5 / UN Meetings / UN Monitor

COVID-19 & LDCs: Upcoming opportunities to address structural impediments

By Elena Marmo and Barbara Adams
The United Nations and Member States begin the 2021 calendar confronted with the need to address the ongoing COVID-19 crisis and growing global inequalities. Despite the WHO’s efforts to make the COVID-19 vaccine “affordable and accessible for all” through the ACT Accelerator and calls by CSOs and UN leadership and world leaders for a People’s Vaccine (a global public good free from Intellectual Property Rights), the global vaccine distribution/rollout has been dominated by wealthy, developed countries, with little if any vaccines available for small and medium developing countries. Read more